Top Markets
#1 MowCat MowCat +367.85%
#2 龙虾 (Lobster) 龙虾 (Lobster) +76.80%
#3 Cortex Cortex +31.42%
#4 DexNet DexNet +23.19%
#5 Magma Finance Magma Finance +18.74%
#6 Akedo Akedo +16.83%
#7 MANTRA MANTRA +16.21%
#8 OpenEden OpenEden +15.58%
#9 MarsCoin MarsCoin +15.19%
#10 BNB Attestation Service BNB Attestation Service +14.84%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A

Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A

300026
Rank in Stocks #7671
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and... Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves the fields of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases. The company was founded in 1996 and is headquartered in Tianjin, China.
Share Price
$0.4999529
Market Cap
$1.50B
Change (1 day)
-0.86%
Change (1 year)
-9.91%
Country
CN
Trade Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A (300026)

Category

Healthcare
P/S ratio for Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A (300026)
P/S ratio as of 2026 TTM: 0
According to Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
2.29 -
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT